• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
BioMérieux and Sema4 Complete Strategic Acquisitions

BioMérieux and Sema4 Complete Strategic Acquisitions

by Glenn S. Demby | May 31, 2022 | Articles, Essential, Industry Buzz-lir, Laboratory Industry Report

Two of the biggest merger and acquisition-related deals that came down in May involved BioMérieux and Sema4

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Healthcare M&A Deal Volume & Size Bottom Out in First Quarter

Healthcare M&A Deal Volume & Size Bottom Out in First Quarter

by Glenn S. Demby | May 2, 2022 | Articles, Deals-lir, Essential, Laboratory Industry Report

Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Biopharma M&A Expected to Rebound After Sluggish 2021

Biopharma M&A Expected to Rebound After Sluggish 2021

by Glenn S. Demby | Mar 1, 2022 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting

PerkinElmer Turns COVID Cash into Acquisitions While Myriad Genetics Keeps Divesting

by Glenn S. Demby | Jun 14, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com